Anne Bergenström is a public health professional with over 25 years of professional experience including on social science and epidemiological research on injection drug use, HIV and HCV, as well as having worked as an adviser on HIV prevention and harm reduction. She has a PhD from the Royal Free and University College Medical School and a MSc in Epidemiology from the London School of Hygiene and Medicine, United Kingdom. Since 2000, she mostly worked in the Asia Pacific region, including with UNAIDS, UNICEF, UNODC and the Johns Hopkins University Bloomberg School of Public Health, before joining the EMCDDA in March 2019. She currently works as Scientific analyst on health in the EU4Monitoring Drugs (EU4MD) project.